for the Period Ended 29 February 2024
Balance sheet | |
Additional notes | |
Community Interest Report |
As at
Notes | 2024 | 2023 | |
---|---|---|---|
|
£ |
£ |
|
Members' funds | |||
Profit and loss account: |
|
|
|
Total members' funds: |
|
|
The notes form part of these financial statements
The directors have chosen not to file a copy of the company's profit and loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 29 February 2024
Basis of measurement and preparation
for the Period Ended 29 February 2024
2024 | 2023 | |
---|---|---|
Average number of employees during the period |
|
|
This year, One.Surgery has continued to maintain its web presence and remained committed to producing online content related to global surgery. While we have not embarked on significant new projects, our focus has been on sustaining our active initiatives and contributing to the global surgery community. Building upon our mission of advancing equity in global surgery, we have proudly supported the creation and development of a global surgery peer-reviewed journal. This endeavor has aimed to make the publishing process more accessible and equitable, allowing researchers from all corners of the world to share their important contributions to the field of global surgery. We remain steadfast in our commitment to fostering collaboration and supporting the global surgery ecosystem as we look forward to the year ahead.
No consultation with stakeholders
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
23 November 2024
And signed on behalf of the board by:
Name: Saqib Noor
Status: Director